We previously used a novel biomedical optics technology, 4-dimensional elastically scattered light fingerprinting, to show that in experimental colon carcinogenesis the predysplastic epithelial microvascular blood content is increased markedly. To assess the potential clinical translatability of this putative field effect marker, we characterized the early increase in blood supply (EIBS) in human beings in vivo. Methods: We developed a novel, endoscopically compatible, polarization-gated, spectroscopic probe that was capable of measuring oxygenated and deoxygenated (Dhb) hemoglobin specifically in the mucosal microcirculation through polarization gating. Microvascular blood content was measured in 222 patients from the endoscopically normal cecum, midtransverse colon, and rectum. If a polyp was present, readings were taken from the polyp tissue along with the normal mucosa 10-cm and 30-cm proximal and distal to the lesion. Results: Tissue phantom studies showed that the probe had outstanding accuracy for hemoglobin determination (r 2 ‫؍‬ 0.99). Augmentation of microvasculature blood content was most pronounced within the most superficial (ϳ100 m) layer and dissipated in deeper layers (ie, submucosa). EIBS was detectable within 30 cm from the lesion and the magnitude mirrored adenoma proximity. This occurred for both oxygenated hemoglobin and DHb, with the effect size being slightly greater for DHb. EIBS correlated with adenoma size and was not engendered by nonneoplastic (hyperplastic) polyps. Conclusions: We show, herein, that in vivo microvascular blood content can be measured and provides an accurate marker of field carcinogenesis. This technological/biological advance has numerous potential applications in colorectal can-
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Background & Aims:
We previously used a novel biomedical optics technology, 4-dimensional elastically scattered light fingerprinting, to show that in experimental colon carcinogenesis the predysplastic epithelial microvascular blood content is increased markedly. To assess the potential clinical translatability of this putative field effect marker, we characterized the early increase in blood supply (EIBS) in human beings in vivo. Methods: We developed a novel, endoscopically compatible, polarization-gated, spectroscopic probe that was capable of measuring oxygenated and deoxygenated (Dhb) hemoglobin specifically in the mucosal microcirculation through polarization gating. Microvascular blood content was measured in 222 patients from the endoscopically normal cecum, midtransverse colon, and rectum. If a polyp was present, readings were taken from the polyp tissue along with the normal mucosa 10-cm and 30-cm proximal and distal to the lesion. Results: Tissue phantom studies showed that the probe had outstanding accuracy for hemoglobin determination (r 2 ‫؍‬ 0.99). Augmentation of microvasculature blood content was most pronounced within the most superficial (ϳ100 m) layer and dissipated in deeper layers (ie, submucosa). EIBS was detectable within 30 cm from the lesion and the magnitude mirrored adenoma proximity. This occurred for both oxygenated hemoglobin and DHb, with the effect size being slightly greater for DHb. EIBS correlated with adenoma size and was not engendered by nonneoplastic (hyperplastic) polyps. Conclusions: We show, herein, that in vivo microvascular blood content can be measured and provides an accurate marker of field carcinogenesis. This technological/biological advance has numerous potential applications in colorectal cancer screening such as improved polyp detection and risk stratification.
T he realization that colon carcinogenesis involves both discrete mutational events and more diffuse epigenetic/cellular abnormalities (field carcinogenesis) has potential clinical consequences. For instance, colonoscopic removal of focal lesions (adenomatous polyps) has been shown to dramatically reduce the incidence of future colorectal cancers (CRCs). 1 On the other hand, identification of field effect in the rectosigmoid may predict risk of neoplasia throughout the colon. 2 Commonly used means of sensing field carcinogenesis include flexible sigmoidoscopy, in which a distal adenoma portends an approximately 2.5-fold increased risk of neoplasia in the proximal colon. 3 Rectal aberrant crypt foci number may be a harbinger of adenomas/carcinomas elsewhere in the colon. 4 However, these field-effect identification modalities generally are insensitive, hindering their use for population screening. Therefore, attention has focused on detecting biomarkers that represent earlier changes of carcinogenesis. Several lines of evidence suggest that there are profound cellular (increased proliferation 5 and decreased apoptosis 6 ), biochemical (eg, protein kinase C activity 7 ), genomic (microarray), 8 and proteomic 9 abnormalities in the histologically normal mucosa of patients harboring neoplasia. Although this provides powerful corroboration of the field effect, these techniques lack the requisite performance characteristics for clinical use.
Our multidisciplinary colon cancer prevention group has been interested in bridging advances in bio-optical technologies into clinical practice. We recently developed 4-dimensional elastic light-scattering fingerprinting, 10 which allows quantification of the colonic mucosal microvasculature. By using this approach, we observed that mucosal microvascular blood content was increased in the histologically normal mucosa of 2 experimental models of colonic neoplasia: the azoxymethane (AOM)-treated rat and the multiple intestinal neoplasia (MIN) mouse. 11 These occurred before the development of adenomas or even aberrant crypt foci. Importantly, this early increase in blood supply (EIBS) was confined to the regions where future neoplasia would develop. This was confirmed using conventional techniques (Western blot analysis for hemoglobin from colonic mucosal scrapings), although Western blot analysis was markedly less sensitive than 4-dimensional elastic light scattering fingerprinting. 11 Although the biological mechanisms remain incompletely elucidated, studies in the AOMtreated rat implicate the role of nitric oxide synthase (iNOS). 12 Taken together, these findings suggest that EIBS may be a useful marker for colon carcinogenesis. To confirm these findings in human beings and to characterize the relationship with concurrent neoplasia we, therefore, performed studies mapping microvascular blood content during colonoscopy. Our results indicate that EIBS is detectable in vivo and its magnitude mirrors proximity to neoplasia, potentially suggesting future clinical utility for enhancing endoscopic polyp detection.
Materials and Methods

Endoscopically Compatible Fiberoptic Probe
We developed an endoscopically compatible fiberoptic probe to assess microvascular blood content in vivo. Figure 1A illustrates the probe design. This probe provides a simplified version of 4-dimensional elastic lightscattering fingerprinting in that it measured wavelength and polarization of scattered light but not scattering angle or azimuthal angle of scattering. One of the three 200-m-core diameter multimode fibers is used as an illumination channel to deliver broadband light from a xenon lamp onto tissue surface whereas 2 fibers serve as collection channels for scattered light from the tissue. Two thin film polarizers are mounted on the proximal tip to polarize the incident light and to enable collections of backscattered light that was polarized parallel (copolarized signal I ʈ ) and perpendicular (cross-polarized signal IЌ) to the incident light polarization. The graded refractive index lens (outer diameter, 1.8 mm; pitch, 0.25) attached to the fiber tip collimated the light incident onto the tissue with half-angle divergence of 3°and focused backscattered light onto the collection fibers. The design ensured that the collection fibers received scattered light from the same tissue site, avoided specular reflectance, and improved the signal-to-noise ratio. In the proximal probe end, the linear array of fibers was coupled to an integrated charge coupled device spectrometer that recorded the spectra of I ʈ and IЌ in the spectral range from 280 to 780 nm. The outer diameter of the fiberoptic probe was 2.5 mm ( Figure 1B and C) , thereby enabling easy passage through the colonoscope biopsy port.
To specifically assess the mucosal microvasculature, the probe preferentially sampled backscattered light from superficial tissue depth (ϳ100 m) via polarization gating. 13 The differential polarization signal ⌬I ϭ I ʈ Ϫ IЌ, copolarized signal I ʈ , and cross-polarized signal IЌ are sensitive to progressively deeper tissue depths. For a given polarization signal, the penetration depth is determined by the angle between incident and collected light beams and the sizes of the illumination and collection spots on tissue surface. These are, in turn, defined by the lens focal length, fiber numeric aperture, and fiber-to-fiber separation. We tested several probe configurations to optimize penetration depth for colonic mucosa.
Spectroscopic Determination of Blood Content
The unique absorption spectra of oxygenated hemoglobin (OHb) and deoxygenated hemoglobin (DHb) in the visible range allowed hemoglobin quantification Imaging and Advanced Technology continued through a Beer's law-inspired algorithm. 11, 14 Briefly, we assumed minimal path length variability owing to differences in optical properties. Therefore, the attenuation caused by absorption has an inverse exponential relationship with the absorber concentration:
where I() is one of the polarization components of the collected light (⌬I, I ʈ , or IЌ), and I scattering () represents the scattering signal if the sample were devoid of absorbers. A() represents the absorption spectrum of all of the absorbers present (predominantly OHb and DHb in the colonic mucosa), and ␣ is the coefficient that represents the product of path length and Hb concentration under the constraints of Beer's law. Extinction coefficients ␣ OHb and ␣ DHb were used to account for different contributions of OHb and DHb. These were obtained from published sources and corrected for hemoglobin packing (originally described by Finlay and Foster) . 15 This phenomenon occurs because hemoglobin molecules within the same erythrocyte may shield each other from the incident light. In addition, the nonerythrocyte sample volume provides many possible light paths that do not sample hemoglobin. This can be corrected through multiplying the standard absorption spectrum in a homogeneous solution by a distortion coefficient described by Foster. In the more realistic scenario of red blood cells within a blood vessel, the packaging effect is no longer simply owing to the cells themselves but rather the length scale of the packaging of red blood cells inside a blood vessel (R). In our analysis, we used packaging length scale R as a fitting parameter. Deduction of ␣ HbO2 and ␣ Hb values from equation 1 required assuming that the form of the scattering spectrum, I scattering (), could be represented by a smooth second-order polynomial lacking the characteristic hemoglobin absorption peaks at 542 nm and 576 nm in the case of OHb and 555 nm in the case of DHb. The parameters ␣ HbO2 , ␣ Hb , and R were chosen by a nonlinear optimization MATLAB (MathWorks Inc, Natick, MA) routine such that the sum of square error between calculated and measured spectra in the range of 480 -680 nm is minimized.
The end result of the analysis is 6 values characterizing blood content in superficial (eg, mucosal) tissue: concentrations of OHb and DHb for each of the 3 depths of penetration. Although simplistic, this Beer's law-inspired relationship was able to fit our data well because of the short depth of penetration of the polarization signals (from 100 to 170 um).
Tissue Phantom Studies
We used tissue phantom experiments to determine the fiberoptic probe's penetration depth and accuracy of blood content measurement. For penetration depth, aqueous suspensions of microspheres with various scattering properties in the range of colon tissue (anisotropy coefficient g, 0.73-0.93; mean free path length ls, 90 -289 m) were used. [11] [12] [13] [14] The polarization signals were collected from tissue phantoms of various thickness (ϳ50 m to 4 mm). Then, we estimated each representative penetration depth from ⌬I, I ʈ , and IЌ as the average of optical thickness (optical thickness , ϭ ls*L; ϭ 1 represents one scattering event on average) by the rate of the increase of the polarization signals with tissue phantom thickness.
To validate the accuracy of spectroscopic measurement of hemoglobin concentration using the fiberoptic probe, we used known concentrations of human Hb (0 -15 g/L from Sigma-Aldrich, St Louis, MO) in the microsphere suspension. Then this true concentration was compared with the one determined using the spectral analysis.
Human Studies
This study was performed under the supervision of the Institutional Review Board of Evanston-Northwestern Healthcare. Patients undergoing screening colonoscopy at Evanston Hospital were recruited for the study. Exclusion criteria included incomplete colonoscopy, poor preparation, and colitis. After intubation of the cecum, the polarization-gated spectroscopy probe was inserted and approximately 10 measurements (each requiring 50 ms) were taken from the endoscopically normal mucosa from the cecum, midtransverse colon, and rectum. The probe was placed in contact with minimal pressure with the colonic mucosa. If a polyp was seen during the colonoscopy, readings from the polyp, from less than 10 cm, and from 10-to 30-cm proximal and distal to the lesion were taken before polyp removal. All polyps were removed by a technique at the endoscopist's discretion. Polyp size was assessed based on endoscopic estimate (using open biopsy as a comparator). All polyps underwent histologic analysis by a board-certified pathologist. Based on endoscopy and pathology, patients were classified in 1 of 3 groups based on their largest polyp: advanced adenoma (size Ն 10 mm, Ͼ 25% villous component, or presence of high-grade dysplasia), adenoma (nonadvanced), or no dysplasia (no adenoma identified).
Statistical Analysis
To assess possible demographic/lifestyle characteristics that might represent confounding factors, we used multivariable linear regression analyses on EIBS values in the largest subgroup (those without neoplasia). Covariates included sex, age, current status of alcohol intake, current smoking status, personal history of polyps from previous colonoscopy, personal history of CRC, and family history of CRC from first-degree relatives. All statistical calculations were performed using STATA 9.0 for Windows (Stata Corp., College Station, TX).
Results
Probe Validation
First, we investigated the depth selectivity for the 3 different polarization signals. The phantom studies using optical properties of colonic tissue showed that differential polarization signal ⌬I, copolarized signal I ʈ , and cross-polarized signal IЌ selected backscattered light within the optical depth () of 2.0 Ϯ 0.7, 2.6 Ϯ 0.8, and 3.4 Ϯ 0.6, respectively. A ϭ 1 corresponded to a physical penetration depth of approximately 50 m given that the mean free path l s of light has been measured to be approximately 50 m in colonic mucosa. 9 Therefore, the optical depths correspond to physical penetration depths of 100 Ϯ 35 m, 130 Ϯ 40 m, and 170 Ϯ 30 m, respectively. Thus, the differential polarization signal ⌬I corresponded to the epithelial (pericryptal) capillary network.
Second, we determined the accuracy of spectral Hb concentration measurement by using tissue phantoms with known concentrations of Hb. This experiment was repeated for different tissue phantoms scattering properties (g ϭ 0.73-0.9, l s ϭ 50 -118 m). Figure 2 shows representative measurements of Hb concentrations obtained from one of the tissue phantoms (l s ϭ 80 m). Calculated Hb concentrations had strong linear correlations with the actual concentrations over the large range of both the physiologic Hb concentration and scattering properties in colonic tissue for all 3 depths (r 2 Ͼ 0.99 for all depths). The spectral measurement error for the 3 penetration depths (ϳ100, ϳ130, and ϳ170 m) were 5%, 12%, and 19%, respectively, over the Hb concentrations (0 -15 g/L). Thus, the spectroscopic approach allows accurate measurement of Hb concentrations over a wide range of tissue optical properties.
We also wanted to ensure that the probe is capable of providing reliable readings during colonoscopy. To this end, the probe was tested in a series of in vivo experiments evaluating mucosal hemoglobin measures under various conditions. First, endoscopic illumination had a negligible effect on the signal recorded by the probe (Ͻ1%). Second, endoscope bending and angulation (including 180°) for practically relevant radii of curvatures (Ͼ5 cm) had a minimal effect (Ͻ1% of signal level and Ͻ1% of the difference in blood content values obtained). Third, we investigated the effect on EIBS of the tissue pressure exerted by the probe using 10 patients (106 tissue sites probed) ( Figure 3A ). During colonoscopy, measures were taken with low, medium, or high pressure against the tissue. Low pressure corresponded to the probe lightly touching the tissue surface, whereas high pressure was sufficient to visibly indent the tissue surface. There were no significant differences in measured Hb concentration for any of the pressure levels (analysis of variance [ANOVA] P Ͼ .92; standard deviation [SD] owing to the pressure effect, 4%). Fourth, similarly, the probe tip angle was studied during colonoscopy (10 patients, 85 tissue sites probed). The angle between the normal axis of the probe tip and the surface normal was varied among 0°-10°, 30°-50°, and 60°-90°. Data indicated that the angle did not have a significant effect on the Hb content measurements (ANOVA P Ͼ .41; SD, 11%; Figure 3B) . Fifth, finally, we evaluated the effect of colonic distension (10 patients, 148 tissue sites), which was varied from nondistended to a highly distended colon, thus spanning the normal operating range during colonoscopy ( Figure 3C ). The distension did not impact Hb measurements (ANOVA P Ͼ .76; SD, 5%). These results indicate that the specifics of probe surgery in vivo do not have a significant effect on Hb content assessment and the implementation of the endoscopically compatible probe can be feasible in any clinical setting.
Patient Characteristics
For the main study assessing EIBS in the colon, we recruited 222 patients undergoing colonoscopy. Of these, 175 subjects had no neoplasia (no adenomas detected), 35 had nonadvanced adenomas, and 12 had advanced adenomas. The mean age of the cohort was 56.6 years and 40% were women. There was no significant difference in sex between the control and any adenoma groups (P ϭ .21 using a test of differences in 2 proportions). The age of subjects in the no-neoplasia and adenoma groups also was comparable (P ϭ .96). Furthermore, groups did not significantly differ in tobacco or alcohol history.
Assessment of Diagnostic Depth for EIBS Markers
The probe uses polarization gating to measure OHb and DHb contents at 3 unique penetration depths. To ascertain the optimal penetration depth for sensing adenomas, the OHb and DHb determinations for each depth from adenoma-free patients were compared with corresponding readings from the uninvolved mucosa in adenoma-harboring patients. The magnitude of difference appeared to be greatest for the approximately 100-m depth for both OHb and DHb (Figure 4) . Indeed, the only statistically significant difference for either OHb or DHb readings between controls (no neoplasia) and adenoma-harboring patients was at 100 m. This tissue depth corresponded to the mucosal pericryptal capillary network obtained in the MIN mouse and the AOMtreated rat using our bench-top instrument. 11 This supports the concept that only a fraction of the total colonic blood supply (the most superficial) is involved in the phenomena of EIBS, thus underscoring the importance of polarization gating to selectively probe this area and avoid being overshadowed by blood from deeper tissues.
EIBS Mirrors Proximity to Neoplastic Lesions
To assess the spatial variation in mucosal EIBS (total Hb, OHb, and DHb) with respect to distance from the adenoma, we focused on the tissue depth of approximately 100 m. We measured the adenomatous polyp, uninvolved mucosa at approximately 10 cm, and at approximately 30 cm from the lesion (both proximally and distally with distance estimated with a straightened colonoscope during withdrawal). The data were normalized to same-site readings from neoplasia-free patients because of the modest variability in basal microvascular readings. For instance, in non-adenoma-harboring patients, the absolute values from the rectum, midtransverse colon, and cecum for DHb was 2.98 g/L, 2.44 g/L, and 2.12 g/L, respectively (ANOVA P Ͻ .001), whereas the total hemoglobin values were 8.62 g/L, 7.65 g/L, and 7.63 g/L, respectively (P Ͻ .01). Figure 5A shows that at the adenoma site the total Hb concentration was increased 75.3% above control levels (comparable region from nonadenoma-harboring patient) and persisted in the uninvolved mucosa. Moreover, tissue sites located within 10 and 30 cm away from an adenoma also manifested a highly statistically significant increase in both total Hb, OHb, and DHb concentrations (P Ͻ .001).
Total Hb, OHb, and DHb readings gradually diminished with distance from the lesion. In general, the percentage of oxygenation was associated inversely with adenoma proximity, with a 14.0% reduction as readings were taken from approximately 10 cm compared with approximately 30 cm from the adenoma, leading to a less-robust gradient with OHb than DHb or total Hb (data not shown). In Figure 5 , the spatial gradients for total Hb and DHb are shown individually. Once again, there is a highly statistically significant increase in blood concentration with proximity to the adenoma (ANOVA P Ͻ .00001 for both total Hb and DHb). DHb had a slightly stronger spatial gradient than total Hb, possibly reflecting increased tissue oxygen extraction in the proximity of the tumor.
With regards to performance characteristics, EIBS measured 30 cm away from the lesion was reasonably accurate in detecting advanced adenomas (sensitivity, 92%; specificity, 78%; negative predictive value, 99.7%; and positive predictive value, 9.4%). These estimates should be viewed cautiously because they are based on relatively modest patient numbers.
Effect of Polyp Size and Histology on EIBS
We noted that the microvascular blood content was increased in the uninvolved mucosa in both advanced and nonadvanced adenomas ( Figure 6A ). However, it was apparent that the magnitude of EIBS engendered by larger lesions was greater than smaller lesions. Specifically, in the uninvolved mucosa approximately 10 cm from a lesion, EIBS (depth of ϳ100 m) was higher if the lesion was an advanced adenoma vs a smaller (nonadvanced) adenoma (P ϭ .0150 and .000263 for total Hb and DHb, respectively, Figure 6A ). This was even more pronounced if the readings were taken from the adenomatous tissue, as shown in Figure 6B . Indeed, the differences between Hb concentration measured from advanced adenomatous polyps vs nonadvanced adenomas was highly statistically significant (P Ͻ .00001 for total Hb and DHb, respectively).
We also wanted to determine whether EIBS is specific for premalignant lesions or may be associated with polyps believed to be innocuous (hyperplastic polyps). Figure 6C shows increased total Hb and DHb readings from the hyperplastic polyp tissue but not from the endoscopically normal tissue surrounding these polyps (ANOVA P ϭ .437 and .392, respectively). These results suggest that EIBS is specific to clinically relevant lesions only and would not be confounded by the presence of hyperplastic polyps. 
Potential Confounders of EIBS: Patient Factors
There are numerous factors that are known to affect colonic blood flow. To date, however, most of these factors have been assessed only at the larger blood vessels (large arterioles and arteries) and not the microvasculature. Therefore, we evaluated the influence of nonneoplastic factors on EIBS. We performed multivariable linear regression analysis on OHb and DHb (depth, ϳ100 m) using no-neoplasia subjects (our largest category). The coefficient ␤ represents EIBS marker change expressed as a percentage of mean values of EIBS markers in the control group. As shown in Table 1 , sex was the only demographic factor that had a significant effect on OHb, with men values averaging 15.0% greater than women. This was consistent with the DHb data (19.1% increase in men). DHb had significant associations with personal and family history of colonic neoplasia (46.4% and 29.1% lower, respectively), but it needs to be emphasized that the sample size was very small (4 patients), highlighting the need for caution in interpreting these data. We also looked at the differences in colonoscopic preparations (oral saline phosphate solution vs polyethylene glycol) and noted no alterations in either total or deoxygenated Hb (P ϭ .83 and .87, respectively; data not shown).
Discussion
We report, herein, that in vivo microvascular blood contents were increased in the endoscopically normal mucosa of patients who harbored colonic neoplasia. These data provide human validation for our previous ex vivo report that EIBS is an early event in field carcinogenesis in both the AOM-treated rat and the MIN mouse. Importantly, EIBS increased in magnitude with proximity to the lesion. Although there did appear to be dose-dependence (ie, the magnitude of EIBS was greater in advanced adenomas than diminutive), it should be noted that even smaller adenomatous polyps manifested EIBS. However, hyperplastic polyps (nonneoplastic lesions) did not engender EIBS in the uninvolved mucosa. This suggests that EIBS may have both biological and clinical significance.
Previous studies have shown that neovascularization could occur as early as the small adenoma 16 or even aberrant crypt foci stage. 17 The only report to date on histologically normal mucosa is a vascular casting study that showed that the "transitional mucosa" (normal epithelium adjacent to CRCs) had abnormal microcirculation. 18 Our detection of EIBS is largely owing to the unique ability of 4-dimensional elastic light-scattering fingerprinting to accurately assess the superficial microvasculature (pericryptal capillary plexus). Although representing only a small amount of the colonic blood supply, it is the compartment that would be anticipated to be most responsive to the hyperproliferative and hence hypermetabolic needs of field carcinogenesis. Consistent with this was our finding that when we gated the blood content analysis to 170 m (submucosa), the difference in hemoglobin content between adenoma-harboring and no-neoplasia patients was diminished markedly. In this regard, it is interesting to note that the spatial trend in DHb was more pronounced than OHb, leading us to postulate that the hypermetabolic epithelium adjacent to a lesion derives sustenance by both increasing the microcirculatory volume and also improving oxygen extraction efficiency.
The other major technologic innovation that permitted in vivo EIBS detection was simplification and miniaturization of the equipment to allow the development of a lightscattering probe. This enabled more accurate Hb content determination without the potential artifacts associated with ex vivo analysis. Moreover, measuring in vivo enabled assessment oxygenation status of the microvasculature given the distinctive light absorption signature of oxygenated vs deoxygenated blood. Thus, the polarization-gated spectroscopy probe enables a more accurate probing of the microvasculature.
The increased microvascular blood content is a promising marker of field carcinogenesis. The phenomena of EIBS appeared to have 2 distinct facets: a low-amplitude diffuse increase throughout the colonic mucosa and more marked augmentation in the region of a tumor. Other markers of the field effect have been reported to also have diffuse and/or localized characteristics. For instance, the ubiquitous nature of field carcinogenesis is underscored by the ability of the rectal mucosa to predict proximal neoplasia through analysis of cellular markers (decreased apoptosis 6 and increased proliferation 5 ) and morphologic markers (aberrant crypt foci 4 or adenomas 3 ). Furthermore, genomic (cyclooxygenase 2, osteopontin) 8 and immunohistochemical (eg, cytochrome C oxidase subunit I) 19 markers showed no clear diminution with distance. On the other hand, markers such as carcinoembryonic antigen, although found in the peritumor histologically normal mucosa, rapidly dissipated with distance. 20 Thus, there is biological precedence that EIBS, being a biomarker for field carcinogenesis, would manifest both diffuse and localized elements.
One would anticipate that the mechanisms involved in EIBS also would reflect this 2-component model. Although Imaging and Advanced Technology continued the biological underpinnings of EIBS remain incompletely understood, several lines of evidence implicate nitric oxide, a potent vasodilator and pro-angiogenic factor in colon carcinogenesis. For instance, in the premalignant AOMtreated rat colonic mucosa, iNOS expression was increased diffusely in the uninvolved mucosa and paralleled the magnitude of colonic mucosal microvascular blood content. 12 Importantly, short-term treatment with an iNOS inhibitor completely abrogated EIBS arguing for causality. 12 With regards to the localized effects, we postulate that it is related to factors elaborated by the tumor (resulting in vasodilation and/or angiogenesis). This also may be nitric oxide-related because numerous reports have shown that iNOS is overexpressed in human colonic adenomas and carcinomas. 21 Other putative factors would include vascular endothelial growth factor, prostaglandins, and so forth. Further studies are needed to elucidate the role of iNOS and other vasodilatory/pro-angiogenic factors as mediators for the 2 components of EIBS. The critical role of augmented blood supply (angiogenesis) in established CRC leads us to postulate that EIBS may be biologically important in early neoplastic transformation of the colon. From a teleologic perspective, increased microvascular blood supply would be essential for supporting the hyperproliferative epithelium that is a hallmark of early colon carcinogenesis. This is supported further by the observation that germline mutations in the vascular-regulatory endoglin 1 is associated with an increased CRC risk. 22 Indeed, as of late, there has been interest in using antivascular strategies to prevent neoplasia (angioprevention). 23 Intriguingly, many agents that target putative EIBS mediators also have shown outstanding chemopreventive activities. For example, there are a number of studies that have indicated that iNOS inhibitors prevent neoplasia in experimental models of colonic neoplasia. 24 Cyclooxygenase 2 is a potent regulator of angiogenesis in colon carcinogenesis and is overexpressed in both the uninvolved mucosa and dysplastic tissues. 25 Cyclooxygenase 2 inhibitors, such as celecoxib, have been shown to be both anti-angiogenic and potent in suppressing colon neoplasia in clinical trials. 25, 26 Moreover, in the MIN mouse, the observation that targeting the vascular endothelial growth factor receptor-2 decreased tumor multiplicity is consistent with our data on the role of EIBS in the initiation of colon carcinogenesis. 27 Thus, our finding of EIBS may provide important biological insights of early colon carcinogenesis.
The endoscopic detection of EIBS has several potential applications, especially given the 2-component model discussed. For instance, the EIBS gradient may potentially be able to serve as a tool to improve colonoscopic detection of adenomas. The clinical imperative is underscored by the observation that 5.1% of patients with newly diagnosed CRCs had a negative colonoscopy within the past 5 years. 28 Moreover, tandem colonoscopy studies have reported that 22% of all adenomas are missed, 29 whereas CT colography indicates that colonoscopy fails to detect 12% of advanced adenomas. 30 In clinical practice, the miss rate is manifested by the large interendoscopist variability in the detection rate for all adenomas and advanced adenomas (3-to 6-fold, respectively). 31 One could envision microvascular blood content being sampled in each third of the colon (each measurement taking ϳ50 ms). If EIBS is increased, this could serve as a red flag for the endoscopist. If the lesion is not visualized, then mapping the EIBS gradient could potentially allow more precise localization. This approach could be of particular value in patients with inadequate preparation or if cecal intubation was not achieved. Potential applications of the diffuse component of EIBS would be for risk stratification through interrogation of the rectal mucosa (data not shown). Finally, this approach may be useful as the optical biopsy in distinguishing hyperplastic polyps from adenomas through probing the surrounding mucosa. However, at this juncture, all these potential applications of EIBS detection are purely theoretical.
There were a number of limitations to our studies. First, the colonoscopy miss rate means that we probably underestimated the magnitude of the increased microvascular blood content related to carcinogenesis (some controls actually harbored adenomas). In addition, the colon distance measures are inexact secondary to colonoscope looping. Also, polyp size estimated by endoscopy may be somewhat inaccurate. 32 Although hyperplastic polyps generally are considered innocuous, right-sided lesions may be a precursor of the sessile serrated adenomas that are associated with microsatellite unstable cancer. 33 However, the vast majority of hyperplastic polyps in our study were located in the distal colon. Colitis was an exclusion criteria because mucosal blood content can be altered by inflammation. However, confounding is unlikely given that colitis generally is readily endoscopically recognizable. Elucidating the mechanisms for EIBS (vasodilation and/or neo-angiogenesis) is of importance for application development. Finally, although our data do support the concept of EIBS measurements to improve colonoscopic polyp detection, risk stratification, and optical biopsy, this has not been proven. Future studies are planned to address all these issues.
In conclusion, we show that the microvascular blood content increased diffusely in the microscopically normal colonic mucosa of patients harboring adenomas. Moreover, the magnitude mirrored the proximity to the neoplasia. This observation was detectable because of the technologic breakthrough in biomedical optics, polarization-gated spectroscopy. EIBS may provide potentially important insights into early events in colon carcinogenesis. Future studies will further investigate both the biological mechanisms and potential clinical applications.
